Trial Information
The Role of IMP3 Expression in Patients With Neuroblastoma
Inclusion Criteria:
- Neuroblastoma patients with complete follow-up and sufficient samples for study.
Exclusion Criteria:
- Neuroblastoma patients without complete follow-up
- Neuroblastoma patients without sufficient samples for study.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Principal Investigator
Wen-Ming Hsu, M.D, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
National Taiwan University Hospital
Authority:
Taiwan: Department of Health
Study ID:
201002039R
NCT ID:
NCT01121419
Start Date:
January 2008
Completion Date:
January 2009
Related Keywords:
- Neuroblastoma
- Neuroblastoma
- IMP3
- Prognosis
- Neuroblastoma